Walden University

ScholarWorks
Walden Dissertations and Doctoral Studies

Walden Dissertations and Doctoral Studies
Collection

2018

A Staff Education Project and Screening Tool to
Identify Calciphylaxis
Janice Pennington
Walden University

Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Nursing Commons, and the Public Health Education and Promotion Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been
accepted for inclusion in Walden Dissertations and Doctoral Studies by an authorized administrator of ScholarWorks. For more information, please
contact ScholarWorks@waldenu.edu.

Walden University
College of Health Sciences

This is to certify that the doctoral study by

Janice Pennington

has been found to be complete and satisfactory in all respects,
and that any and all revisions required by
the review committee have been made.

Review Committee
Dr. Sue Bell, Committee Chairperson, Nursing Faculty
Dr. Casey Cole, Committee Member, Nursing Faculty
Dr. Francisca Farrar, University Reviewer, Nursing Faculty

Chief Academic Officer
Eric Riedel, Ph.D.

Walden University
2018

Abstract
A Staff Education Project and Screening Tool to Identify Calciphylaxis
by
Janice M. Pennington

MSN, Walden University, 2007
BS, University of the State of New York, 1984

Project Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Nursing Practice

Walden University
May 2018

Abstract
Calciphylaxis is a deadly disease seen primarily in patients with end stage renal disease.
Literature indicated that improved patient outcomes are seen with routine screenings.
Many dialysis providers lack fundamental knowledge that would enable early
identification of calciphylaxis in patients with renal disease. The purpose of this project
was to design a screening instrument and develop a staff education program that would
transform calciphylaxis management by promoting early identification and treatment of
the disease. Knowles’s theory of andragogy was used as the theoretic framework for the
project. Dialysis center staff (n = 26) participated in the education. The number of
participants was based on the number of staff working at the partner dialysis site. There
were no exclusions as all members of the interdisciplinary team play an important role in
calciphylaxis management. Surveys conducted following the education were used to
determine whether dialysis staff believed they had acquired the knowledge and skills
necessary to identify early signs of calciphylaxis. Descriptive data collected by the
surveys indicated 60% of participants were not at all comfortable identifying patients at
risk for developing calciphylaxis prior to attending the education presentation. Following
the presentation, 68% of participants felt very comfortable identifying at-risk patients, an
increase of 82.3%. This project exemplified that calciphylaxis detection is a secondary
prevention nursing intervention that has potential for promoting positive social change by
improving patient outcomes, reducing mortality rates in the end stage renal disease
population, and providing empirical data to inform evidence-based therapies for at-risk
patients.
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Section 1: Nature of the Project
Introduction
End-stage renal disease (ESRD) occurs when the kidneys can no longer clear the
body of uremic toxins. ESRD is the most severe stage of chronic kidney disease and
requires renal replacement therapy to sustain life (National Kidney Foundation, 2002).
The U.S. Renal Data System (USRDS) reported 703,243 prevalent ESRD cases in the
United States at year end in 2015 (Saran et al., 2017). This represents 0.21% of the U.S.
population, an increase of 2.4% from the previous year and a 58% increase from the year
2000 (Saran et al., 2017). Likewise, the incidence of ESRD has also been on the rise. As
reported by the USRDS, there were 112,114 newly diagnosed ESRD cases in 2015
(Saran et al., 2017). Chronic kidney disease and ESRD not only affect population health
but can also represent a health-related quality of life (HRQOL) burden for the individual.
Frequent hospitalizations and increased mortality risks have been associated with poor
HRQOL (Chen, Mawed, & Unruh, 2016). Multiple comorbid conditions such as anemia,
disordered bone metabolism, cardiovascular disease, and infections are all factors that
negatively impact a person’s HRQOL. As the incident and prevalent rates of ESRD have
continued to rise, there has been an increased demand upon health care resources to
manage the life-sustaining needs of the ESRD population as well as treating the many
associated comorbidities (Saran et al., 2017).
Calciphylaxis is a serious disease seen predominately in the ESRD population.
The disease process has been described as calcifying panniculitis, necrotizing
panniculitis, calcific uremic arteriolopathy (CUA), nonuremic calcific arteriolopathy, and
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calcinosis cutis. Hans Seyle first described calciphylaxis in 1962 as an anaphylactic
reaction to calcium (Nigwekar et al., 2015). While this description does not accurately
describe the pathology of calciphylaxis, the term is universally known. For this reason,
the term calciphylaxis will be used throughout this paper.
Brandenburg et al. (2016) described calciphylaxis as a “challenging disease with a
dismal prognosis urgently requiring adequate strategies for diagnosis and treatment” (p.
1211). Calciphylaxis is a form of extraskeletal calcification characterized by the
deposition of calcium salts in the subcutaneous tissues (Zacharias, Fontaine, & Fine,
1999) and thrombosis of the small arterioles of the skin (Moorthi & Moe, 2011). In
advanced stages, calciphylaxis can lead to tissue ischemia, necrosis, and pain (Jeong &
Dominguez, 2016). Calciphylaxis has been reported to affect from 1% to 4% of the
ESRD population (Brandenburg et al., 2016). According to Nigwekar et al. (2014), actual
epidemiological counts are difficult to quantify because there is no unique International
Classification of Diseases (ICD) code specific for calciphylaxis. Under ICD-10,
calciphylaxis is coded as E83.59 – other disorders of calcium metabolism. This
nonspecific classification has led to a lack of precise epidemiological data, making it
difficult to fully appreciate the prevalence of calciphylaxis or to track disease trends
accurately. Additionally, as Nigwekar et al. argued,
lack of data on fundamental issues such as incidence, prevalence, or mortality for
any condition seriously impairs future patient-oriented translational research and
limits investigators’ abilities to examine temporal trends, epidemiological
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associations, and development of diagnostic biomarkers and novel therapy targets.
(pp. S924-S925)
For this reason, there seems to have been a void in evidence-based research to guide the
treatment of calciphylaxis. One prevalent theme in the literature indicated that routine
screening, early identification, and early intervention of calciphylaxis could improve
patient outcomes. Despite this, research regarding any screening process has been
lacking. There is a practice gap with regards to conducting routine screenings and, as
Brandenburg et al. noted, many providers lack the knowledge and skills necessary to
identify early signs of calciphylaxis. For this DNP project, I have looked to fill the
practice and knowledge gaps by developing a calciphylaxis screening tool to use in
clinical practice and developing a staff education project to provide dialysis staff with the
knowledge and skills necessary to identify calciphylaxis in the ESRD population.
Positive social implications could be realized through early detection and treatment of
calciphylaxis, thereby reducing the physical burden of advanced disease and reducing
health care spending.
Problem Statement
As reported by the USRDS, the nephrology community has seen an alarming
increase in the incident and prevalent dialysis population in the 35-year period from 1980
through 2015. Trends in incident and prevalent ESRD populations are documented
annually by the USRDS. In 1980, there was a reported incident ESRD count of 17,902
with an adjusted rate (million/year) of 87 and a reported prevalence count of 56,434 with
an age-sex-race standardization per million of 273.7 (Saran et al., 2017). Compare this to
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current trends in 2015. In 2015, there was a reported incident ESRD count of 124,114
with and adjusted rate (million/year) of 357 and a reported prevalence count of 703,243
with an age-sex-race standardization per million years of 2,023.6 (Saran et al., 2017).
This rapid growth in the ESRD population coupled with increased awareness of the
disease process is likely responsible for an increasing number of patients now being
diagnosed with calciphylaxis.
Late stages of calciphylaxis are characterized by vascular calcification, tissue
necrosis, and the ensuing development of painful skin ulcers (Magro, Simman, &
Jackson, 2010). While calciphylaxis pathogenesis remains a mystery (Bliss, 2002),
researchers do know that the ulcerative lesions are associated with considerable pain,
suffering, and a mortality rate 2.5 to 3 times higher than in ESRD patients without
calciphylaxis (Nigwekar et al., 2014). Although there are no data on the number of
patients who are misdiagnosed or whose diagnosis is delayed, the importance of early
diagnosis and treatment is well documented. The lack of evidence regarding routine
calciphylaxis assessment and screening has clearly indicated that there is gap in clinical
practice that calls for action. Parker, Mouton, Young, and Espino (2003) reported a
calciphylaxis associated mortality rate of 86%, while Wangen, Anderson, Fencl, and
Mangan (2014) reported a median survival of 2.6 months following diagnosis.
Calciphylaxis lesions are often seen as soft tissue calcifications or ulcerative wounds of
the skin. The underlying pathology of calciphylaxis is related to endoluminal calcification
of the vasculature and, as such, calciphylaxis can affect any other organ system.
Calciphylaxis has been noted to affect the heart and gastrointestinal tract (Magro et al.,
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2010). Not all calciphylaxis is ulcerative or systemic. As Fine and Zacharias (2002)
noted, calciphylaxis can be nonulcerating and often goes undiagnosed. Herein lies the
need for routine calciphylaxis screening in the ESRD population. With the current trends
in ESRD epidemiology, routine screening for calciphylaxis becomes crucial.
Patients with chronic kidney disease carry a higher burden for cardiovascular
disease than the general population (Saran et al., 2017). According to the USRDS,
cardiovascular death is the largest category of known cause mortality in the ESRD
population (Saran et al., 2017). In 2015, cardiovascular deaths were broken down into the
following categories: 40% arrhythmia and cardiac arrest, 6% acute myocardial infarction
and arteriosclerotic heart disease, 3% congestive heart failure, 3% cerebral vascular
accident, and 3% other cardiac causes (Saran et al., 2017). Systemic calciphylaxis has
been implicated as contributing to the high rate of cardiovascular death among patients
with chronic kidney disease due to cardiac artery calcifications (Lee, Belozeroff, Song,
Diakun, & Goodman, 2013). Evidence-based treatment of calciphylaxis has remained
elusive. Literature supported improved outcomes if calciphylaxis was identified and
treated prior to the onset of ulcerative lesions (Feeser, 2011; Sprague, 2014). A practice
void has persisted because the literature is devoid of evidence or even expert opinions
that would inform a process for conducting routine calciphylaxis screening.
As a nurse practitioner practicing in the outpatient hemodialysis unit, I have
personal experience to indicate that the incidence of calciphylaxis with ulcerative lesions
is becoming more prevalent than in previous years. This is no doubt a reflection of a
growing ESRD population and increased clinical awareness. Fine and Zacharias (2002)
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found a high prevalence of nonulcerating calciphylaxis in their dialysis population and
concluded that the incidence of calciphylaxis is much higher than described in the
literature. If this is true, then health care teams are doing a disservice to the ESRD
population and need to become more proactive in early screening and disease detection.
Whether due to underdiagnosis or a growing ESRD population, calciphylaxis
presents a population health challenge. There is a knowledge gap in hemodialysis clinical
practice as well as the absence of any screening tool to inform clinical assessment. Filling
this gap may assist nurses and advanced practitioners to recognize the early signs of
calciphylaxis that, if left unchecked, could potentially lead to advanced disease. This
presupposes a need for educational training to provide dialysis nurses with the
foundations and skills necessary to recognize impending serious sequela. Despins, ScottCawiezell, and Rouder (2010) recognized that quality care could be improved if nurses
had the tools available to help them identify risk factors or early signs of impending
injury.
This DNP project has the potential to transform calciphylaxis management by
nephrology nurses. With development of a calciphylaxis screening tool and education of
nurses on how to use the tool in clinical practice, this DNP project could lead to the
transformation of nephrology nurses into clinical nurse leaders in calciphylaxis
management.
Purpose
A gap analysis of calciphylaxis management revealed a knowledge gap, as many
nephrology nurse providers do not know how to identify physical signs of calciphylaxis.
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There also exists a practice gap in that routine calciphylaxis screenings are not being
conducted.
The purpose of this DNP project is twofold: first, to design a calciphylaxis
screening tool that could be used in clinical practice and second, to develop a continuing
nurse education activity that would provide dialysis staff with the education and skills
necessary to conduct a clinical screening for the purpose of identifying calciphylaxis in
the clinical setting.
This DNP project addressed two practice focused questions:
1. What are the best practices based on literature evidence and expert opinion to
be incorporated in a calciphylaxis assessment and screening tool?
2. Will dialysis staff who participate in a staff education activity, regarding
calciphylaxis assessment and screening, acquire the knowledge and skills
necessary to effectively identify calciphylaxis in the clinical setting?
It is clear from the research that there is a lack of evidence or opinions regarding
best practices in the management of calciphylaxis. Brandenburg et al. (2016)
acknowledged unmet medical needs in calciphylaxis management that are due to the
scarcity of evidence. Brandenburg et al. identified an urgent need for clinical guidance in
this area of medicine. With this DNP project, I addressed the practice void by developing
an assessment tool that, once validated, could be used to guide the process of routine
calciphylaxis screening.
A successful calciphylaxis screening program is dependent on nurses who possess
a fundamental knowledge of calciphylaxis and can apply this knowledge in clinical
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practice. This DNP project addressed the knowledge gap with the development of a staff
education activity that provided dialysis staff with the fundamental knowledge and the
core competencies to conduct a calciphylaxis screening and identify calciphylaxis lesions
in clinical practice.
The Nature of the Doctoral Project
A literature search failed to produce any nursing protocol related to screening,
identification, or treatment of calciphylaxis in the ESRD population. There have been
numerous case studies, some anecdotal evidence, and expert opinion, but there was a
dearth of solid evidence. The literature search was replete with references to the lack of
evidence or best practices. What I derived from the evidence was that early identification,
diagnosis, and intervention is paramount to improving outcomes and minimizing
complications (Feeser, 2011; Fine & Zacharias, 2002; Sprague, 2013).
There were two components to the DNP project. The first was to design a
calciphylaxis screening tool that could be easily integrated into clinical practice without
being unduly burdensome or disrupting unit workflow. The assessment and screening
tool was designed to incorporate the current monthly diabetic foot exam and pain
assessment. Development of the assessment and screening tool was based on current
evidence and expert opinion regarding calciphylaxis pathophysiology; best practices in
skin and wound assessment, screening, and surveillance; and a multidimensional pain
assessment. Once developed, the assessment and screening tool was offered to
participants during the continuing education activity for evaluation and to solicit
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recommendations for improvement. The tool was not validated as part of the DNP project
but is expected take place outside of the DNP project.
The second element of the DNP project involved working with a partner dialysis
organization to provide dialysis staff with the knowledge and skills necessary to conduct
a routine calciphylaxis screening. The staff education activity offered attendees 1.5 hours
of continuing education credits. The objectives of the presentation were to educate
participants (a) to understand the pathophysiology of calciphylaxis, (b) to identify
patients at risk of developing calciphylaxis, and (c) to provide the skills needed to
identify calciphylaxis lesions in the clinical setting. This staff education project was
designed to incorporate an interdisciplinary approach for achieving early intervention by
empowering frontline nurses to assume a proactive leadership role, apply critical
assessment skills, assess risk factors, and identify potential signs of calciphylaxis in the
dialysis patient population.
I used several evaluation techniques for data analysis. A retrospective pre/post
self-assessment was developed to evaluate the participants’ perceptions of learning and
competence in caring for patients with calciphylaxis. A posttest was conducted to
evaluate knowledge transfer, retention, and application of calciphylaxis principles that
would be needed to conduct a calciphylaxis screening. The activity specific outcome
measure assessed what changes participants could implement into practice. A shared
enduring activity evaluation was used to evaluate the effectiveness of teaching strategies.
Finally, an evaluation of the calciphylaxis screening tool helped examine functionality,
usefulness, and relevance to practice.
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Significance
Calciphylaxis is a disease that can adversely affect the health and wellbeing of the
affected individual. Calciphylaxis is said to affect 1% to 4% of the dialysis population
(Brandenburg et al., 2016), but this may not be an accurate epidemiological measure (Fine
& Zacharias, 2002; Nigwekar et al., 2014). As the nephrology community sees increasing
numbers of ESRD patients, it is likely that there will be an increased number of
calciphylaxis cases diagnosed. Calciphylaxis is associated with a high mortality rate
(Parker et al., 2003; Wangen et al., 2014) and a reduced HRQOL (Jeong & Dominguez,
2016). Yet, despite the gravity of the disease, there is very little evidence available to
guide therapy. The evidence pointed to early recognition and treatment as being
paramount to reducing complications and improving outcomes (Fine & Zacharias, 2002).
The goal of this DNP project was to fill a practice gap limiting frontline dialysis staff
from critically assessing the patient for attendant risk factors and identifying early stages
of the disease. The ultimate outcome would be to educate frontline nurses with the
knowledge they need to lead clinical practice change and improve health care outcomes
for the ESRD patient.
Summary
The landscape of medicine was transformed by two important reports published
by the Institute of Medicine: To Err is Human, Building a Safer Health Care System
(1999) and Crossing the Quality Chasm: A New Health System for the 21st Century
(2001). The onus is on health care providers to deliver safe, quality, and patient-centered
care. Nurses are being called upon to become leaders in clinical practice and at the
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bedside (Grindel, 2016). Nephrology nurses are ripe for assuming clinical leadership
roles to improve outcomes for the ESRD population who are at risk of developing
calciphylaxis.
A calciphylaxis diagnosis comes with a high price tag in terms of patient
outcomes, quality of life, morbidity, and mortality (Chen et al., 2016; Nigwekar et al.,
2014; Sprague, 2014). The aggressive treatments and multimodal therapy associated with
the treatment of advanced disease often result in considerable health care costs. Routine
calciphylaxis assessment and screening could lead to early identification and intervention
before the development of ulcerative lesions or other systemic complications. Aggressive
management of the disease in its early stages could ultimately save health care dollars
and improve clinical outcomes. The development of a calciphylaxis assessment and
screening tool and instituting routine calciphylaxis screening could be one process that
changes the landscape of health care in nephrology through disease prevention.
Calciphylaxis is most prevalent in the ESRD population, but it is not exclusive to
this population. Cases have been reported in patients with chronic kidney disease,
primary hyperparathyroidism, multiple myeloma or other plasma cell proliferative
disorders, cirrhosis, and rheumatoid arthritis (Magro et al., 2010). This DNP project
focused on the ESRD population, but the lessons learned can easily be applied to any of
the vulnerable populations.
In Section 2, I will address how Knowles’s www.amsn.org (1984; Knowles,
Holton, & Swanson, 2005) theory of adult learning was integrated into the staff education
project.

12
Section 2: Review of the Evidence
Introduction
Early recognition of calciphylaxis is paramount to early intervention and
treatment in order to minimize complications and disease progression. A gap analysis
found that education regarding identification of calciphylaxis wounds was necessary to
groom dialysis providers to perform a routine calciphylaxis screening. A practice gap
analysis found no available calciphylaxis assessment tools to inform routine screening or
a problem-focused assessment.
Dialysis nurses, as integral members of the interdisciplinary team, are best
positioned to assume a leadership role at chairside and positively impact quality
outcomes in the ESRD population. Because of the close contact between ESRD patients
and nephrology providers, the ensuing patient–provider bond can facilitate an open twoway communication channel. A nurse properly trained to preform calciphylaxis screening
is in an excellent position to recognize early calciphylaxis lesions and avert the
complications associated with advanced disease.
The first purpose of this DNP project was to develop a calciphylaxis screening
tool that could be used in clinical practice. The second purpose was to create a staff
education activity that would educate dialysis nurses how to conduct a calciphylaxis
screening and assessment in the ESRD population. This DNP project addressed two
practice focused questions:
1. What are the best practices based on literature evidence and expert opinion to
be incorporated in a calciphylaxis assessment and screening tool?
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2. Will dialysis staff who participate in a staff education activity, regarding
calciphylaxis assessment and screening, acquire the knowledge and skills
necessary to effectively identify calciphylaxis in the clinical setting?
The staff education activity and draft calciphylaxis screening tool were offered to
staff at the partner dialysis facility. While the calciphylaxis screening tool is important, it
requires validation before it can be disseminated. Validation is expected to take place
outside of this DNP project.
In this section, I will discuss the application of Knowles’s (1984; Knowles et al.,
2005) theory of adult learning to the staff education activity. I will examine the gaps in
practice that prompted this DNP project. Further, I will examine how my experiences at
my partner organization helped to shape my role as an educator, interprofessional
collaborator, and leader to transform care at the chairside and improve population health
in the ESRD population.
Concepts, Models, and Theories
Malcolm Knowles (1913-1997) was a U.S. educator renowned for developing the
theory of adult learning (Bates, 2009). Knowles’s first book, published in 1973, described
the unique needs of the adult learner. This book is now in its eighth edition. Knowles
differentiated the learning needs of children from those of the adult. Pedagogy, or the
teaching of children, is a teacher-centric model of education (Knowles et al., 2005).
Under a pedagogical model, the teacher determines the subject matter, the manner of
instruction, and the evaluation methods (Knowles et al., 2005). Student participation is
passive as the teacher leads the learning experience (Knowles et al., 2005). In contrast,
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andragogy is defined as the “art and science of helping adults learn” (Knowles et al.,
2005, p. 61). In an andragogic model, the focus shifts from a teacher-centric emphasis on
learning to a learner-centered approach that motivates learning. In andragogy, the role of
the teacher shifted from leading learning to facilitating learning (Knowles et al., 2005).
The andragogic model is based on six assumptions of adult learning (Knowles,
1984; Knowles et al., 2005):


Need to know: Adult learners need a reason for learning. If knowledge
acquisition is meaningful, then the learner will find benefit in learning.



Self-concept: Mature adults assume responsibility for making their own
decisions. They become self-directed, goal directed, and independent learners.



Prior life experience: The varied backgrounds and experiences present in a
group promote a “rich resource for learning” (Misch, 2002, p. 154) that can be
capitalized upon to enhance the learning experience.



Motivation: Motivators for learning can include job advancement, monetary
incentives, grades, self-improvement, self-satisfaction, or personal fulfilment.



Readiness to learn: Readiness to learn occurs when learning coincides with
need-to-know situations, managing life challenges, or achieving life goals
(Misch, 2002).



Relevance: Learning must be relevant and life-centered. Adult learning is
problem centered and geared toward knowledge that is situationally applicable
(Misch, 2002).
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To integrate the principles of adult learning in an educational offering, the role of
the teacher must shift to one of a process manager rather than focusing on only
disseminating information (Knowles, 1984). Teaching strategies should be fashioned to
facilitate participant interaction. Interactive teaching strategies could include discussion,
case studies, work groups, brainstorming, problem solving, polling, and self-reflection.
Such interactions tend to stimulate thinking, promote active participation, and most
importantly can capitalize on varying life experiences of each participant.
The application of Knowles’s andragogic principles can be applied to any adult
learning situation whether in the live classroom, virtual classroom, distance learning, selfstudy, continuing education, or human resource development. In this DNP project,
Knowles’s theory of adult learning was used to develop an interactive staff education
project that focused on the pathophysiology of calciphylaxis, identification of
calciphylaxis wounds, treatment, and outcomes. While the staff education project was a
live event, it could easily be adapted and delivered as a webinar or in an online forum.
Relevance to Nursing Practice
Calciphylaxis is a disease that carries a high mortality rate. Fine and Zacharias
(2002) concluded that nonulcerating calciphylaxis carried a mortality rate of 33% at 6
months and increased to greater than 80% with the development of ulcerative lesions.
The findings by Fine and Zacharias suggested that nonulcerating plaque lesions likely
represented early calciphylaxis and, if treated, could prevent progression to advanced
disease, which is characterized by ulcerative lesions. Fine and Zacharias’s findings also
indicated that because nonulcerative calciphylaxis is often undiagnosed or misdiagnosed,
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the incidence of calciphylaxis is much higher than what has actually been published in
the literature.
The precise pathophysiology of calciphylaxis remains a mystery, but there are
certain known risk factors. A disordered calcium and phosphorus metabolism is
implicated as one of the leading predisposing factor to calciphylaxis (Rudolph & Lerma,
2012). The cardiovascular disease that is seen in the ESRD population can be exacerbated
by calciphylaxis as a result of calcium deposition in the large vessels (Chandra et al.,
2012; Magro et al., 2010) or with metastatic calcification in the myocardium (Mana,
Sanguineti, Unterseeh, Bouvier, & Garot, 2012). A literature search produced no
evidence of existing nursing protocols for routine calciphylaxis screening. During my
search, I was only able to locate a single study with discussion of routine calciphylaxis
screening. In their study, Fine and Zacharias (2002) found that most of their newly
diagnosed calciphylaxis cases presented with dense plaques in the calf. They concluded
that (a) nonulcerating calciphylaxis lesions were more prevalent than ulcerative lesions,
(b) nonulcerating calciphylaxis lesions probably represented early disease, and (c) an
experienced clinician could easily identify these calciphylaxis plaques during a routine
screening (Fine & Zacharias, 2002). While often misdiagnosed as cellulitis, the plaques
were often due to calcium deposition in the subcutaneous tissue, were tender on
palpation, and could usually be seen on bone scan (Fine & Zacharias, 2002). Fine and
Zacharias stated that they did routinely conduct screening for nonulcerative calciphylaxis
at their peritoneal dialysis clinic. Unfortunately, they did not provide any specific
recommendations on how to conduct a screening or offer a clinical screening instrument.
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Despite the growing awareness of this horrific disease process, there remains
insufficient scientific evidence to guide treatment or routine screening. But, as Fine and
Zacharias (2002) indicated, experienced practitioners could easily identify nonulcerative
calciphylaxis lesions with routine screenings. A nurse-driven calciphylaxis screening
protocol conducted by nurses trained to identify nonulcerative lesions could potentially
improve patient outcomes in patients with calciphylaxis. A screening protocol proven to
be effective in the ESRD population could be implemented in the general population to
screen patients at risk for developing calciphylaxis. Addressing this practice gap in the
local ESRD population could also provide an opportunity for developing empirical data
to inform evidence-based therapies for all patients at risk.
Local Background and Context
During my practicum experience, I worked with my partner facility as a member
of the core team. The core team comprised a group of interdisciplinary professionals who
provided direct patient care. The core team fulfilled several functions. I will review those
that were directly applicable to my practicum experience and DNP project.
Quality Outcome Measures
The core team was responsible for reviewing patient and facility quality outcome
measures as established by the Centers for Medicare & Medicaid Services (CMS). These
quality measures are used to assess unit-specific quality and performance outcomes. They
include dialysis adequacy, anemia management, mineral and bone disorders, nutritional
status, infection rates, hospitalization rates, and standard mortality rates. The core team
identified trends and developed a plan to correct any measures that did not meet goals.
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Organizational Goals
Nursing staff competencies and staff retention rates were integral to good patient
outcomes. The core team identified a problem with high staff turnover, resulting in a
higher ratio of inexperienced nurses in relation to experienced nurses. As a result, the
core team identified nursing education as a priority. During my tenure on the core team, I
assumed the role of educator and presented on topics such as fall prevention, adverse
drug events, and medication nonadherence. These presentations were also developed
using a Knowles’s framework.
According to Chaghari, Saffari, Ebadi, and Ameryoun (2017), staff education is
necessary to maintain core competencies, quality outcomes, patient outcomes, and job
satisfaction. Staff education in nursing can help strengthen the health care organization
by improving employee productivity, fostering innovative thinking, improving patient
outcomes through best clinical practices, and stimulating a desire for lifelong learning
(Chaghari et al., 2017). In the case at hand, dialysis staff was motivated to learn how to
apply evidence-based principles and transform care at the bedside to improve patient
outcomes. They were able to immediately apply what they learned to problems
encountered in clinical practice. This resulted in increasing self-confidence building
skills. Increased self-confidence leads to job security, job satisfaction, and ultimately staff
retention.
Calciphylaxis as a Focus for my DNP Project
The core team identified a trend in the increasing number of patients with
calciphylaxis. Patients with calciphylaxis require an aggressive multimodal and
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multidisciplinary treatment plan. Treatments can include (a) increasing the dialysis time
and frequency, (b) managing serum phosphate levels using one or more phosphate
binders, (c) suppressing the parathyroid gland with calcimimetics and bisphosphonates,
(d) preventing hypercalcemia by limiting exposure to extrinsic calcium and vitamin D,
(e) administering intravenous sodium thiosulfate to chelate calcium deposits in the
subcutaneous tissue, and (f) managing pain. If indicated, surgical interventions could
include parathyroidectomy for hyperparathyroidism and wound debridement to facilitate
wound healing. Adjuvant hyperbaric oxygen therapy has also been used for wound
healing. Patients with calciphylaxis are often comanaged by specialists in infectious
disease, wound care, and pain management. Calciphylaxis can negatively impact a
number of the quality outcome measures set out by CMS. Calciphylaxis screenings are
not typically performed, and in my literature review I was unable to uncover any
validated clinical assessments available to conduct a routine calciphylaxis screening. To
address this practice gap, I developed a calciphylaxis assessment and screening tool that
could be used in clinical practice.
Despite all that is known about the devastating effects of calciphylaxis, there
remains a practice void and absence of tools to effectively screen patients for
calciphylaxis. This DNP project was one approach in bridging the local calciphylaxis
knowledge gap and could potentially address the knowledge and practice gaps identified
in the nephrology community at large.
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Role of the DNP Student
As a nurse practitioner practicing in the outpatient hemodialysis setting, I found
an increased incidence of advanced ulcerative calciphylaxis cases being diagnosed
outside of the dialysis unit. This prompted a question of why calciphylaxis was not
recognized in the dialysis setting. Two themes came to light. First, dialysis staff was not
looking for calciphylaxis and second, dialysis nurses were not prepared to identify
calciphylaxis wounds or conduct routine screenings for calciphylaxis.
Patients who reach advanced stages of calciphylaxis have poorer outcomes and
higher mortality rates. To improve outcomes, calciphylaxis needs to be diagnosed in its
early stages. Most hemodialysis patients receive treatments several times a week. This
frequent contact puts dialysis professionals in the best position to screen for early
manifestations of the disease. Currently, dialysis nurses conduct monthly foot inspections
in their diabetic patients and a monthly pain assessment on all patients. Calciphylaxis
management should become an integral part of dialysis care and should start with routine
screenings. A calciphylaxis screening program could be implemented without a
significant disruption in nursing workload and for a minimal cost simply by building
upon the diabetic foot exam and pain assessment. My proposal to design a calciphylaxis
screening tool and develop a contemporaneous staff education program has the potential
to improve patient outcomes, reduce calciphylaxis-related hospitalization, and reduce
health care spending.
My role as the DNP student was to develop the screening tool and the staff
education project. I designed the education to include the topics of calciphylaxis
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pathophysiology, individual risk factor assessment, typical skin changes, staging of
lesions, treatment strategies, and pain assessment. I stressed the role of nurse leader to
effectively transform care at the chairside and to spearhead practice changes that could
improve outcomes subsequent to disease prevention. Several evaluation methods were
employed to determine knowledge transfer and application to nursing practice. These are
fully discussed in Section 4.
Summary
While previously under recognized, the burden of calciphylaxis is now coming to
the forefront. Calciphylaxis is a fatal disease. More research is needed to determine if a
nurse-driven calciphylaxis screening program could improve calciphylaxis-related
outcomes, but first nurses need the tools to accomplish this task. A logical source in
which to find such screening tools should be in the published literature. However, a
diligent search revealed that there was little to no relevant material available. Therefore,
it became necessary to develop a calciphylaxis screening tool from the ground up. No
matter how effective or successful this tool may be, it is useless in the hands of an
untrained provider. Therefore, provider education plays an integral part in calciphylaxis
management.
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Section 3: Collection and Analysis of Evidence
Introduction
Calciphylaxis is a disease frequently referenced in literature, but it has been
poorly studied and there is little evidence to inform practice. One message consistently
threaded throughout the literature was that early identification and treatment of
calciphylaxis is paramount to improved patient outcomes and quality of life. There was
no evidence to inform recommendations for routine screening. Fine and Zacharias (2002)
found that calciphylaxis was nonulcerative in the early stages and could be identified
through routine screening. Fine and Zacharias indicated that routine screenings were
performed in their peritoneal dialysis patients. Unfortunately, Fine and Zacharias did not
provide any information regarding how to screen for the disease nor did they provide a
screening tool. Despite this evidence, now 15 years later, best practices are still lacking.
This DNP project focused on two objectives. The first objective was to design an
evidence-based calciphylaxis screening and assessment tool that could be used in clinical
practice to inform routine calciphylaxis screenings in the ESRD population. The second
objective was to develop a staff education activity to provide dialysis nurses with the
baseline knowledge that would enable them to screen for early calciphylaxis and identify
nonulcerative calciphylaxis lesions.
A literature search failed to produce any existing calciphylaxis screening
instrument. There were no randomized control trials, systematic reviews, or clinical
practice guidelines to inform a calciphylaxis screening. Therefore, I needed to design a
screening instrument from the ground up. To determine best evidence to be included in a
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calciphylaxis screening tool, I had to rely on general search terms to locate data and
design a calciphylaxis screening tool.
In this section, I review evidence regarding wound management, screening for
diabetic Charcot foot, foot assessment in the dialysis patient, and pain assessments. Such
topics laid the groundwork for developing the calciphylaxis screening instrument. I was
then able to use the tool as a template to inform the staff education project and educate
dialysis nurses to conduct a calciphylaxis screening.
Practice-Focused Questions
This DNP project addressed two practice focused questions:
1. What are the best practices based on literature evidence and expert opinion to
be incorporated in a calciphylaxis assessment and screening tool?
2. Will dialysis staff who participate in a staff education activity, regarding
calciphylaxis assessment and screening, acquire the knowledge and skills
necessary to effectively identify calciphylaxis in the clinical setting?
The nephrology community has agreed that calciphylaxis is a population health
concern. Unfortunately, there has been very limited evidence to guide screening,
evaluation, or treatment. Nephrology nurses with the proper training and assessment tool
could be positioned to assume a leadership role, proactively perform a calciphylaxis
screening, and make appropriate referrals for medical management.
The purpose of this DNP project was to address gaps in practice and knowledge
and improve clinical outcomes through staff education. Using Knowles’s (1984; Knowles
et al., 2005) model of andragogy as the theoretical framework, nursing staff were
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educated on calciphylaxis prevention, screening, identification of early calciphylaxis
lesions.
Sources of Evidence
A literature search was conducted electronically using the Walden University
Library, University of New York at Buffalo Library, and a general Internet search.
Databases searched included EBSCO, Medline, CINAHL, ProQuest, Thoreau, Google
Scholar, Google, and the American Nephrology Nurses Association online library.
Search terms included nursing protocol, skin care protocol, ulcers, diabetic ulcers,
wounds, wound assessment, wound management, skin lesions, dermatology,
calciphylaxis, calcific uremic arteriolopathy, CUA, non-uremic calciphylaxis, metastatic
calcification, panniculitis, end-stage renal disease, renal failure, chronic kidney disease,
ESRD, calciphylaxis pain assessment, and pain assessment. In addition, I queried the
American Nephrology Nurses Association ANNA Connected Advanced Practice
Specialty Practice Network regarding any existing nursing protocols for the early
recognition of calciphylaxis lesions. This query failed to produce any existing nursing
protocols, making this uncharted territory.
Russo et al. (2015) underscored the importance of early diagnosis and found
calciphylaxis is undiagnosed in its early stages. Rather, calciphylaxis is usually diagnosed
in the late stage following the development of cutaneous ulcers. The ensuing multimodal
therapy can include medical wound care, surgical wound care, off-label use of sodium
thiosulfate, cinacalcet, hyperbaric oxygen therapy, and parathyroidectomy (Russo et al.,
2015). In my clinical practice, treatment also included an increase in dialysis frequency,
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aggressive reduction in serum phosphorus utilizing multiple phosphate binders, use of
bisphosphonates, frequent laboratory monitoring, and often an infectious disease referral.
The cost associated with multimodal therapy in terms of HRQOL, morbidity and
mortality, health care costs, and clinical outcomes can be nothing more than staggering.
Burdette-Taylor (2015) reported an annual cost of $1.6 billion for the care of new
diabetic foot ulcers and as high as $6 billion inclusive of prior ulcer care. It is
conceivable that these costs pale in comparison with expenditures related to calciphylaxis
multimodal therapy. Burdette-Taylor’s teachings regarding proactive interventions
focused on preventing diabetic ulcers are undeniably applicable to the ESRD population
and calciphylaxis screening.
Feeser (2011) stated, “[p]revention and early diagnosis are essential to successful
management of CUA. Once ulcers develop, there is a dramatic twofold increase in
mortality, strongly suggesting that all possible means should be employed in an attempt
to prevent ulceration” (p. 381). A diagnosis of calciphylaxis is often based on clinical
presentation and patient history (Feeser, 2011). Cutaneous biopsy is the gold standard for
diagnosis, but the biopsy itself can lead to complications such as ulceration, infection
(Feeser, 2011), and poor wound healing of the biopsy site (Wheeler & Singh, 2008). In
actual practice, it has been my experience that health care providers avoid cutaneous
biopsy for these exact reasons. There are several noninvasive studies (plain radiograph,
xeroradiography, soft tissue mammogram, ultrasound, and computerized tomography)
available that can be used to screen for vessel calcification and provide a clinical picture
supporting a diagnosis of nonulcerative calciphylaxis (Feeser, 2011). Wheeler and Singh
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(2008) examined the use of a bone scan to identify soft tissue calcifications as another
noninvasive diagnostic that can confirm a clinical suspicion of early onset calciphylaxis.
The literature search failed to produce any nursing protocols that specifically
addressed identification of early onset calciphylaxis. For that reason, I searched for
information regarding nursing protocols that addressed wound surveillance in diabetic
wounds and conducting a meaningful pain assessment. The theoretical underpinnings of
these disease processes could be applied to a calciphylaxis specific assessment and
screening tool.
Burdette-Taylor (2015) stressed a proactive approach for the assessment, early
identification, and intervention of diabetic patient with lower extremity arterial disease
and lower extremity neuropathic disease. Burdette-Taylor proposed a model to utilize
certified foot and nail care nurses to conduct regular basic foot and lower extremity
examinations for the early identification and treatment of diabetic foot ulcers. While
Burdette-Taylor did not provide any hard evidence to validate the model, the concept of
being proactive can lead to early identification and timely intervention, which can
improve health outcomes and quality of life.
The 1st Consensus Conference on CUA convened in Leuven, Belgium on
September 25, 2015. Thirteen experts in the field of calciphylaxis joined together to form
a consensus opinion regarding standards that could be applied in the prevention,
identification, and treatment of calciphylaxis (Brandenburg et al., 2016). Several
important opinions emerged that are directly applicable to this project and are outlined
below (Brandenburg et al., 2016) and were incorporated in the staff education activity:
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The presence of painful lesions in a setting of ESRD and/or other risk factors
should raise a high suspicion for calciphylaxis.



Common findings in calciphylaxis include pain and firm calcified lesions that
are palpated in the subcutaneous tissues.



Many providers lack the knowledge and skills necessary to identify the early
signs of calciphylaxis.



The use of warfarin is associated with the development of calciphylaxis.



Calcium loading and hyperphosphatemia are not necessarily predictors of
calciphylaxis.



Patients who develop large calciphylaxis lesions have the worst prognosis.

Foot Assessments
I was able to locate two existing DNP projects that could inform development of
the calciphylaxis assessment and screening tool.
Robertson (2013) identified lower extremity amputations in the ESRD population
as a population health problem. To address this problem, Robertson developed a lower
extremity algorithm to guide lower extremity assessment. A short 3-month pilot study
was conducted using the algorithm. Interestingly, by the second month, the patients were
asking staff to assess their feet and actively participated in the exam. The Robertson
study was limited in respect to sample size and study period. There were no correlations
made between the foot assessments and referrals. Despite these limitations, it seemed that
the foot algorithm served to educate and engage patients to participate in self-care
(Robertson, 2013). Robertson also commented that, following the 3-month trial, the
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algorithm was adopted by the dialysis facility for inclusion in their monthly foot
assessment protocol.
Wade (2016) developed an assessment and screening tool to be used by nurse
practitioners in identifying Charcot foot. The tool was developed but not implemented
and therefore utility of the tool was not studied. The tool was validated by two expert
reviewers and Wade disseminated the information among a limited number of nurse
practitioners. Although there has been no evidence supporting actual utility of the tool, I
used it as a model to design the calciphylaxis assessment and screening tool in this DNP
project.
Wound Management Protocols
Catania, Huang, Madison, Moran, and Ohr (2007) discussed how a cancer
hospital improved pressure ulcer quality indicators by engaging and empowering the
clinical team to implement a pressure ulcer prevention protocol intervention (PUPPI).
Prior to implementing the PUPPI, an initial 2003 survey reported a prevalence rate of
19.47% for all ulcers and 12.39% for hospital acquired ulcers (n = 113). National
Database of Nursing Quality Indicators (NDNQI) benchmarks at that time were 12.65%
and 6.84% respectively (Catania et al., 2007). These nurse sensitive indicators exceeded
the national benchmarks by > 50%. Initial efforts to improve pressure ulcer management
were marginally effective (Catania et al., 2007). These improvements, however, proved
to be short lived. After forming a quality improvement (QI) team, a root cause analysis
showed that nursing staff were not fully on board with the intervention. Nursing
implicated a lack of specialty equipment and skin care products (Catania et al., 2007).
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Further analysis by the QI team found inconsistencies in nursing assessments and
documentation that contributed to the poorer outcomes. With this knowledge in hand, the
QI team implemented strategies to engage the nursing staff in this quality improvement
initiative (Catania et al., 2007). In addition, the team evaluated the organizational
commitment to improvement. The resultant PUPPI incorporated specialty patient care
equipment, developed a nurse-driven protocol intervention, actively engaged patient care
technicians who provided direct patient care, incorporated weekly monitoring, and
integrated staff education (Catania et al., 2007). Following implementation of the PUPPI
in September 2004, the hospital realized quality indicators that were well below NDNQI
benchmarks. The study reported outcomes into June 2006. During the report period, not
only did NDNQI benchmarks fall, but so did the hospital’s prevalence data (Catania et
al., 2007). This study underscores that protocols in and of themselves are not enough to
bring about change. Stakeholders must be empowered through education, teamwork, and
organizational commitment.
Aalaa, Malazy, Peimani, and Mohajeri-Tehrani (2012) found that 85% of lower
extremity amputations in diabetics could be prevented with routine nurse-driven patient
education, routine screening, and early intervention of identified diabetic foot
complications. The authors stressed that “education of health care provider is a crucial
issue” (Aalaa et al., 2012, “Nurse’s Role in Education,” para. 4).
Pain Assessment
Acute and chronic pain has been described as prevalent in the ESRD population,
which can negatively affect an individual’s quality of life. Brkovic, Burilovic, and Puljak
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(2016) conducted a systematic review of pain in the hemodialysis population and found
that causes for pain in this population are multifactorial. The authors found that 82% of
participants suffered with acute pain and 92% suffered with chronic pain (Brkovic et al.,
2016). Davison (2007) recognized that the presence of “extremely painful, welldemarcated nonulcerating plaques” (p. 1278) could represent early calciphylaxis. If left
untreated, these wounds could develop into the cutaneous ulcerations seen in progressive
disease. This indicates that the pain associated with calciphylaxis is an important
symptom and that an accurate pain assessment is integral to calciphylaxis screening.
Farahani, Alhani, and Mohammadi (2014) conducted a study to evaluate the pain
assessment skills of pediatric nurses. Pain assessment in pediatrics can be challenging as
infants may not be able to communicate their pain, or young children may not accurately
communicate pain (Farahani et al., 2014). The researchers conducted a quasiexperimental study to determine if a pain committee improved nursing skill sets in pain
evaluation, assessment, and management. The initial needs assessment revealed that, in
general, nurses lacked the knowledge to conduct a systematic pain evaluation (Farahani
et al., 2014). To address this knowledge gap, the researches convened a pain committee
charged with educating the nurses how to conduct a systematic pain assessment.
Following implementation of the pain committee, statistical analysis indicated nurses in
the intervention group possessed superior assessment skills as compared to the nurses in
the control group (P ≤ 0.001) (Farahani, 2014).
The lessons learned from the Farahani et al. (2014) study are applicable to the
dialysis population. As Brkovic et al. (2016) noted, acute and chronic pain is prevalent in

31
the hemodialysis population. The multifactorial nature of pain can make pain assessment
an arduous process. Pain is recognized as the fifth vital sign by the American Pain
Society (Farahani et al., 2014). As the fifth vital sign, it is imperative that dialysis nurses
possess a strong pain assessment skill-set as part of the calciphylaxis screening.
Evidence Generated for Doctoral Project
The staff education project was the focus of this DNP project. I obtained site
specific approval to conduct my research at my partner dialysis facility. Approval at the
partner dialysis facility was granted to include 25 dialysis staff members in the study.
Participants
The number of participants was based on the number of staff working at the unit.
There were no exclusion criteria. Registered nurses and advanced practice nurses would
exclusively conduct routine screenings. Other interdisciplinary team members could
provide education on topics such as dietary management, reduction of complications,
wound care, smoking cessation, and reporting of symptoms. Calciphylaxis management
could be integrated into the interdisciplinary patient care plan of care. Each dialysis staff
member plays an important role in calciphylaxis management and therefore all staff
members were included in the participant pool.
Recruitment of study participants was accomplished through flyers posted within
the dialysis unit. I also extended personal invitations to nurse practitioners who were
credentialed at the partner dialysis facility. Scheduling of the educational activity was
flexible to accommodate staff schedules and maximize staff participation with minimal
disruption in unit activity or patient care.
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Procedures
Any interested dialysis staff member was eligible to participate in the study.
Continuing education credits were provided through Walden University. In order to claim
continuing education credits the participants were required to attend the entire live
presentation, sign on to the website, achieve a passing score on the posttest, complete an
activity specific outcome measure, and complete a shared enduring activity evaluation. In
addition, participants were asked to complete two paper based evaluations following the
live presentation, a retrospective pre/post self-evaluation and an evaluation of the
calciphylaxis assessment and screening tool.
Posttest. The posttest was a method of evaluation to obtain subjective data
regarding knowledge transfer and retention that occurred following the staff education
project. It was completed online and participants were required to obtain a score of 80%
to pass.
Activity specific outcome measure. The activity specific outcome measure
determined what changes the participants could implement into practice that would foster
sustainability and improved patient outcomes. This was completed online and was
required to claim continuing education credit.
Activity evaluation. An activity evaluation was required to claim continuing
education credit. The activity evaluation assessed the effectiveness of the teaching
strategies and provided insight program effectiveness. The feedback obtained can be used
to guide future educational activities.
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Retrospective pre/post self-evaluation. I chose the retrospective pre/post selfevaluation to assess the participants’ subjective perception of competence in managing
calciphylaxis. The retrospective pre/post self-evaluation tool is a validated method for
assessing subjective data. Because this was a blinded study I was not able to conduct a
standard pre/post evaluation designed to measure change as a resulting from staff
education.
Calciphylaxis screening and assessment tool evaluation. This was a paper
based evaluation that was conducted immediately following the live presentation. I used
this evaluation as a means to determine the screening tool’s usefulness, functionality, and
relevance to practice. I also used the evaluation to elicit feedback for improvements and
enhancements to revise the tool.
Protections
I structured my DNP project as a single center, blinded, quasi-experimental
design. Approval was obtained through Walden University Investigational Review
Board. Because of the nature of the study, a signed consent was not required. Participant
anonymity was required by Walden and also by the partner site. All staff members were
provided with a copy of the consent prior to the start of the educational activity. The
consent was reviewed at the beginning of the PowerPoint presentation and an electronic
version of the consent was posted on the online platform. Following the live presentation
the participants were asked to complete the paper based evaluations in my absence. One
participant was designated to collect the completed evaluations and place them in a
manila envelope for delivery to the DNP student. Additional evaluations were completed
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on the online continuing education platform, which was administered by the director of
continuing nurse education at Walden University. This director provided me with the raw
data that was collected while the online platform was active. In this way, participant
anonymity was maintained.
Participants were advised that all project activities were voluntary. Conversely
certain assessments were mandatory for claiming continuing education credits. In this
instance, participants were assured that raw data would be collected in a manner that
maintained anonymity.
Analysis and Synthesis
The project began by designing a calciphylaxis assessment and screening tool
based on the literature evidence and expert opinion. The tool was divided into three
sections: (a) a calciphylaxis risk assessment, (b) a multidimensional pain assessment
using the PEG pain scale, and (c) a skin assessment diagram. I then developed an
educational program and presented this at the partner dialysis site. Utilizing Knowles’s
(1984; Knowles et al., 2005) framework, the educational component focused on the
pathophysiology of calciphylaxis, risk factor identification, wound identification, and
application of the assessment tool in clinical practice. The effectiveness of the education
program was evaluated through a series of assessments to determine knowledge transfer,
the participant’s objective assessment of competence in calciphylaxis management,
strategies for implementing and sustaining change, and finally the feasibility to
implement calciphylaxis screening in clinical practice.
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Summary
I conducted a literature search that failed to produce any nursing protocols
specific to the early identification of calciphylaxis or for conducting a routine
calciphylaxis screening. Yet, calciphylaxis remains a significant health care challenge for
the ESRD population. The concepts related to skin breakdown and diabetic foot ulcers
were applicable to caring for the patient with calciphylaxis. Research in these areas
revealed a benefit to screening and nurse-driven protocols that could easily be integrated
into a calciphylaxis screening protocol. Successful implementation of a calciphylaxis
screening protocol will be dependent upon knowledgeable providers with the skill sets to
effectively conduct comprehensive assessments. To address the practice gap, I designed a
calciphylaxis screening tool that could be implemented into clinical practice. The tool has
yet to be validated. Validation is expected to take place outside of the DNP project.
Calciphylaxis is a deadly disease. There is a need for generating evidence that can
be applied to clinical practice and transform care delivery for patients with calciphylaxis.
In this project, I proposed that calciphylaxis screenings could easily be integrated into
practice by building upon current foot and pain assessments. This could easily be
accomplished with minimal disruption to workflow or interruptions in patient care. I have
addressed the practice and knowledge gaps that would act as barriers to implementation.
Implementation of a calciphylaxis screening has the potential to transform care at the
chairside by applying evidence to improve outcomes in the ESRD population and other
vulnerable populations.
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I sought to determine if a staff education activity would provide dialysis nurses
with the knowledge and skills necessary to identify calciphylaxis in the clinical setting. In
Section 4 I analyzed the data to determine the answer to this question.
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Section 4: Findings and Recommendations
Introduction
Calciphylaxis is estimated to affect 1% to 4% of the ESRD population
(Brandenburg et al., 2016). Poor outcomes and high mortality rates are associated with
calciphylaxis. Research uncovered an abundance of literature describing risk factors, case
studies, recommendations for treatment, and disease trajectories. The one predominant
theme threaded throughout the literature was that patients experience improved outcomes
if the health care provider diagnoses calciphylaxis in the early stages and initiates
treatment prior to the development of ulcerative lesions. While literature supported
routine screening for calciphylaxis, there were no nursing protocols, guidelines, or
clinical instruments that informed routine screening.
One challenge seen in health care models today is the transformation of health
care delivery from treatment to prevention (Ronco, Mason, Karopadi, Milburn, &
Hegbrant, 2014). This DNP project focused on calciphylaxis prevention developing a
screening tool and a staff education program. The goal of the educational activity was to
educate dialysis staff about risk factors, pathogenesis, pain assessment, and wound
identification. Ultimately, dialysis staff should be able to use this knowledge to
implement a screening protocol and calciphylaxis management program in clinical
practice.
Calciphylaxis Screening Tool
Despite an exhaustive literature search and reaching out to other nephrology
providers, I was not able to discern any evidence to guide a routine calciphylaxis

38
screening. Likewise, I was unable to discover any nursing protocols or existing screening
instruments. My research found considerable evidence to support screenings for diabetic
wounds, pressure ulcers, and other skin breakdown. Aalaa et al. (2012) found that nursedriven protocols, routine screenings, and early intervention could significantly reduce the
number of lower extremity amputations in the diabetic population. The nephrology
community is lagging in calciphylaxis wound screening, early intervention, and disease
prevention. It is time that the nephrology community fills this practice void. Designing a
calciphylaxis screening instrument can be one avenue to address this void.
The 1st Consensus Conference on CUA opined that many nephrology providers
lack the knowledge and skills necessary to identify early signs of calciphylaxis
(Brandenburg et al., 2016). Any screening instrument lacks value if the provider using it
lacks a fundamental knowledge of the underlying disease process. For this reason, an
important aspect of this DNP project was not only to design the screening tool, but also to
provide dialysis staff with a foundation to use the assessment form effectively in clinical
practice.
Pain and metastatic calcifications with or without skin ulceration are hallmark
signs of calciphylaxis. The assessment tool focuses on three key aspects in calciphylaxis
pathogenesis: (a) risk factors, (b) a multidimensional pain assessment, and (c) wound
identification. In developing the tool, I was cognizant of the fact that a potential barrier
existed if routine calciphylaxis screenings proved to be burdensome or disrupted unit
workflow. With this in mind, I fashioned a screening tool that capitalized on an
opportunity to expand the current practice of monthly diabetic foot exams and pain
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assessments. After the original design was completed, the screening tool was introduced
during a staff education activity. The participants were asked to evaluate the tool on its
general format, content, relevance to practice, and functionality. Any suggestions for
improvements were incorporated into the final tool (Appendix A). I revised the tool based
on participant suggestions. The tool requires validation before it can be placed into
clinical practice.
Staff Education Program
The primary study was approved by the IRB at Walden University (Approval
Number 06-21-17-0103266). I received formal approval from the clinical research
department at my partner dialysis organization and collected data from dialysis staff for
this project. The project was a single center, blinded, quasi-experimental, mixed method
design. The research question was as follows: Will dialysis staff who participate in a staff
education activity regarding calciphylaxis assessment and screening acquire the
knowledge and skills necessary to effectively identify calciphylaxis lesions in the clinical
setting? The staff education activity, titled “Calciphylaxis: The Dialysis Medusa,” offered
1.5 continuing education contact hours, including 1.5 hours of pharmacology content
through Walden University, an American Nurses Credentialing Center–approved
provider. Inclusion criteria were broad and included anyone interested in learning about
calciphylaxis. There were no exclusion criteria. To claim contact hours, participants were
required to (a) attend the entire live presentation; (b) sign on to an activity-specific
website by November 3, 2017 to complete a posttest, answer an activity specific outcome
measure evaluation, and complete the shared enduring activity evaluation. Participants
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were required to achieve a score of 80% on the posttest and were afforded three
opportunities for successful completion. The website was administered by the director of
clinical nurse education at Walden University.
The Live Activity
Working in conjunction with the director of continuing nurse education at Walden
University, we developed the continuing education activity in accordance with the
accredited provider planning template and educational planning table (Appendix B).
Once finalized, I presented the program dialysis staff at the partner dialysis facility. The
PowerPoint deck that I prepared appears in Appendix C. Content included the history of
calciphylaxis, pathogenesis, cutaneous calciphylaxis, systemic calciphylaxis,
identification of lesions, treatment of calciphylaxis, assessment and disease prevention. I
designed the education to be interactive using Knowles’s (1984; Knowles et al., 2005)
assumptions of adult learning. I scheduled six separate sessions to accommodate the staff
schedules and maximize the participant pool. Each session lasted about 1.5 hours. There
were a total of 26 participants who attended from all job classifications. This was a
student-centered activity and I fostered student engagement by including interactive case
discussions, risk factor identification, question periods, wound identification exercises,
risk factor identification, case study analyses, and incorporated participant lived
experiences in caring for patients with calciphylaxis.
Although assessments, such as screening for calciphylaxis, are typically within
the scope of practice of the registered nurse, I opted to include any member of the
interdisciplinary team in the training. According to Nancarrow et al. (2013), the
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interdisciplinary team includes all professional and nonprofessional staff. The
interdisciplinary team collaborates and brings individual and disciplinary attributes for
the improvement of patient care. The dynamics of the interdisciplinary team include
communication, respect, vision, a shared mental model, and the delivery of patientfocused care (Nancarrow et al., 2013). It is for these reasons that I encouraged all
members of the dialysis team to participate in this education project. The interdisciplinary
team breakdown can be seen in Table 1; registered nurses included 54% of the
participants.
Table 1
Participant Breakdown
Percentage

Nurse Practitioners

Number of
Participants
2

Registered Nurses

14

53.8%

Licensed Practical Nurses

2

7.7%

Patient Care Technicians

2

7.7%

Social Workers

2

7.7%

Dieticians

2

7.7%

Administrative Assistants

2

7.7%

7.7%

In addition to the live presentation, there was a website created and administered
by the director of continuing nurse education at Walden University. This website was
created for participants to apply for continuing education credits. Participants were
required to attest to attending the entire live presentation, achieve a score of 80% on a
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posttest, answer an activity specific/outcome measure evaluation, and complete an
activity evaluation in order to claim for continuing education credit. The online platform
was active from October 4, 2017 to November 3, 2017. A total of 23 participants signed
on to the website. Sixteen participants completed the posttest. Twelve participants
completed all requirements and claimed continuing education credit.
Evaluation of the Educational Activity
I used several evaluation strategies to determine if participants acquired the
knowledge to identify calciphylaxis lesions and to evaluate the effectiveness of teaching
strategies.
Retrospective pre/post self-assessment. The retrospective pre/post assessment
has been found to be an effective method to evaluate learning and knowledge transfer
(Bhanji, Gottesman, de Grave, Steinert, & Winer, 2012). I administered the retrospective
pre/post self-assessment following the live presentation. I used this evaluation to
determine if the participants perceived learning occurred and if they felt confident
applying their new knowledge in the clinical setting. I manually entered participant
responses into the electronic equivalent survey design created online at Survey Monkey
for further analysis.
Posttest. The posttest evaluated knowledge transfer, retention, the application of
calciphylaxis principles, and wound identification. The test comprised 21 questions
covering topics such as pathophysiology; diagnostic criteria; types and stages of
calciphylaxis lesions; systemic calciphylaxis; pharmacological and nonpharmacological
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therapies; and pain assessment. The posttest was administered via the online platform.
The posttest was required to claim continuing education credit
Activity-specific/outcome measure evaluation. The online activity-specific
outcome measure was designed to determine (a) if participants acquired knowledge that
could be applied to assess, identify, and implement procedures that may improve
outcomes for patients with calciphylaxis, and (b) if participants would implement
changes to their practice after attending the educational activity. This evaluation was a
requirement to claim continuing education credit
Shared enduring activity evaluation. Finally, participants completed the share
enduring activity evaluation via the online platform. This evaluation was a requirement to
claim continuing education credit.
Evaluation of the Calciphylaxis Screening Tool
I introduced the initial calciphylaxis screening tool during the educational
activity. Following the presentation, participants were asked to complete a paper based
evaluation of the tool. The evaluation consisted of 10 questions focusing on general
appearance, functionality, usability, relevance to practice, anticipated barriers to
implementation, and an overall rating. I manually entered participant responses into the
electronic equivalent survey created online at Survey Monkey for further analysis.
Findings and Implications
Calciphylaxis is a disease process that has far reaching implications for
individuals and the health care system. Calciphylaxis is associated with a high mortality
rate and has a negative impact on the patients’ HRQOL. The multimodal therapies can
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result in considerable health care expenditures. Yet, as Fine and Zacharias (2002)
concluded, there is a high prevalence of nonulcerative calciphylaxis that goes
undiagnosed, which ideally could be identified with routine screening. Despite their
supposition, 15 years later, there still remains a practice void in terms of calciphylaxis
screening. This DNP project may provide the means for health care transformation from
treatment to prevention.
As discussed above, I conducted several assessments and evaluations throughout
the project. I detailed the findings of each assessment below.
Retrospective Pre/Post Self-Assessment
The retrospective pre/post self-assessment comprised 14 questions. Participants
were asked to evaluate their baseline knowledge and comfort level subjectively prior to
attending the staff education activity. They then compared these answers with their
subjective feelings of learning and competence in identifying calciphylaxis following the
educational activity. Tables 2 to 8 outline participant responses. Overall, there seemed to
be a subjective increase in functional knowledge and feelings of confidence following the
live activity.
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Table 2
Pre/Post Self-Assessment: Response to Questions 1 and 2
Question 1: Describe your level of
knowledge about calciphylaxis
PRIOR to attending this presentation.
Answer Choice

Question 2: Describe your level of knowledge
about calciphylaxis AFTER attending this
presentation.

Number

Percent

Answer Choice

Number

Percent

I never heard of it.

0

0%

I learned nothing new.

0

0%

I’ve heard of it, but I
don’t know much
about it.

8

32%

I learned some new
information about the disease.

2

8%

1

4%

I’ve taken care of a
patient with
calciphylaxis, but I
don’t understand much
about the disease.

4

16%

I have a better understanding
of the disease, but I am NOT
comfortable caring for a
patient with calciphylaxis.

I’ve taken care of a
patient with
calciphylaxis and I
have some
understanding of the
disease.

13

52%

I think I can take care of a
patient with calciphylaxis.

1

4%

0%

I have a better understanding
of the disease and I am
comfortable caring for a
patient with calciphylaxis.

20

80%

0%

I had advanced knowledge of
the disease, but I did learn
some things that I did not
know previously.

1

4%

I’ve never taken care
of a patient with
calciphylaxis, but I
have some
understanding of the
disease.

I have advanced
knowledge.

0

0
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From the responses above, prior to attending the educational activity, only 52% of
participants stated they had some understanding of calciphylaxis. However, after
attending the educational activity, 80% of participants felt they had a better
understanding of the disease and could care for a patient with calciphylaxis. Only one
participant (4%) felt she did not acquire enough knowledge to care for a patient with
calciphylaxis.
The next few sets of questions (see Tables 3, 4, and 5) queried how comfortable
participants felt in identifying patients at risk for developing calciphylaxis and their
comfort levels in identifying different stages of calciphylaxis lesions.
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Table 3
Pre/Post Self-Assessment: Comparison Between Questions 3 and 4

Answer
choices

Question 3: Describe how
comfortable you were at
identifying patients at risk of
developing calciphylaxis
PRIOR to attending this
presentation.
Response
Percent

Question 4: Describe how
comfortable you feel you are at
identifying patients at risk of
developing calciphylaxis AFTER
attending this presentation.
Response

Percent

15

60%

0

0%

A little
comfortable.

7

28%

6

24%

Very
comfortable.

3

12%

17

68%

I am very
knowledgeable.

0

0%

2

8%

Not at all.

Sixty percent of participants were not at all comfortable identifying patients at
risk of developing calciphylaxis prior to attending the presentation. Following the
presentation 68% of participants felt “very comfortable,” an increase of 82.3%.
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Table 4
Pre/Post Self-Assessment: Comparison Between Questions 5 and 6

Answer
choices

Question 5: Describe how
comfortable you were at
identifying nonulcerative
calciphylaxis lesions PRIOR to
attending this presentation
Response
Percent

Question 6: Describe how
comfortable you feel you are at
identifying nonulcerative
calciphylaxis lesions AFTER
attending this presentation
Response
Percent

Not at all.

16

64%

1

4%

A little
comfortable.

8

32%

8

32%

Very
comfortable.

1

4%

14

56%

I am very
knowledgeable.

0

0%

2

8%

Only one participant (4%) felt very comfortable identifying nonulcerative
calciphylaxis lesions prior to attending the presentation as compared to 56% following
the presentation, an increase of 92.85%.
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Table 5
Pre/Post Self-Assessment: Comparison Between Questions 7 and 8

Answer
choices

Not at all.
A little
comfortable.
Very
comfortable.
I am very
knowledgeable.

Question 7: Describe how
comfortable you were at
identifying ulcerative
calciphylaxis lesions PRIOR
to attending this presentation
Response
Percent
16
64%

Question 8: Describe how
comfortable you feel you are at
identifying ulcerative calciphylaxis
lesions AFTER attending this
presentation
Response
Percent
0
0%

8

32%

9

36%

1

4%

14

56%

0

0%

2

8%

Likewise, only one participant (4%) felt “very comfortable” identifying ulcerative
calciphylaxis lesions prior to attending the presentation as compared with 14 participants
(56%) who felt “very comfortable” after the presentation, an increase of 92.85%.
One aspect of the calciphylaxis assessment is to conduct a multidimensional pain
assessment. The PEG pain scale was selected as the multidimensional tool because it is
easily administered at chairside and can evaluate the long-term effects of therapy.
Table 6 examines how comfortable participants felt in conducting a
multidimensional pain assessment using the PEG pain scale to assess calciphylaxis
related pain.
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Table 6
Pre/Post Self-Assessment: Comparison Between Questions 9 and 10

Answer choices

Question 9: Describe how
comfortable you were at
conducting a multidimensional
pain assessment (such as the
PEG pain scale) BEFORE
attending this presentation.

Question 10: Describe how
comfortable you feel you are
conducting a
multidimensional pain
assessment (such as the PEG
pain scale) AFTER
attending this presentation.

Response

Percent

Response

Percent

Not at all.

7

28%

0

0%

A little
comfortable.

13

52%

2

8%

Very
comfortable.

5

20%

21

84%

I am very
knowledgeable.

0

0%

2

8%

Prior to attending the presentation, all registered nurses conducted a monthly pain
assessment using the Wong Baker FACES pain rating scale, a unidimensional pain scale.
According to participant responses, 52% of participants felt “a little comfortable” using a
multidimensional pain assessment. There was an increase of 76.19% in the percentage of
participants who felt “very comfortable” conducting a multidimensional pain assessment
following the presentation.
Table 7 compares how comfortable participants felt in discussing the risks factors
of calciphylaxis with their dialysis population.
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Table 7
Pre/Post Self-Assessment: Comparison Between Questions 11 and 12

Answer
choices

Question 11: Describe how
comfortable you were in
discussing risks of
calciphylaxis with your
patients BEFORE to
attending this presentation.
Response
Percent

Question 12: Describe how
comfortable you are discussing risks
of calciphylaxis with your patients
AFTER attending this presentation.
Response

Percent

Not at all.

12

48%

0

0%

A little
comfortable.

10

40%

4

16%

Very
comfortable.

3

12%

19

76%

I am very
knowledgeable.

0

0%

2

8%

Prior to the presentation, 88% of participants were “not at all” comfortable or only
“a little comfortable” in discussing risk of calciphylaxis with their patient population.
After the presentation 76% of participants felt “very comfortable”, indicating an increase
of 84.2% after attending the presentation.
The final two questions were designed to determine how well the participants
understood that calciphylaxis was not limited to cutaneous manifestations but rather was
a progressive and systemic disease process. Table 8 shows that following the
presentation, 92% of participants appreciated the progressive nature of the disease, an
increase of 52.1%.
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Table 8
Pre/Post Self-Assessment: Comparison Between Questions 13 and 14
Answer
choices

Question 13: BEFORE I
attended this presentation, I
believed that calciphylaxis
only involved the skin.
Response
Percent

Question 14: AFTER attending this
presentation, I believe that
calciphylaxis only involves the skin.
Response

Percent

I don’t know.

5

20%

0

0%

I agree with
this statement.

9

36%

2

8%

I disagree with
this statement

11

44%

23

92%

In conclusion, the results of the retrospective pre/post self-assessment seemed to
support that the educational activity had been beneficial in transferring foundational
knowledge. Additionally, the assessment indicated that the staff achieved a comfort level
in identifying risk factors and cutaneous manifestations of calciphylaxis, and felt they
were better prepared to discuss calciphylaxis with the dialysis patient population.
Posttest
The posttest was conducted online following the live presentation. The test
comprised 21 questions and participants were required to achieve a score of 80% to pass
the test. Participants were afforded three attempts to achieve the target score. The posttest
covered information that was discussed during the live presentation. Sixteen participants
completed the posttest. Eleven participants (69%) achieved a score ≥ 80% on the first
attempt. Four other participants (24%) achieved a score ≥80% on their second attempt.
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One participant (6%) did not achieve the target score on the first attempt and did not retake the test. The average test score by attempt was 81.8% on the first attempt and 85.5%
on the second attempt. Tables 9 and 10 show the test score distribution on the first and
last attempt.
Table 9
Test Score Distribution: First Attempt
Test Score %
29%

Count
1

Percent
6%

52%

1

6%

76%

3

19%

81%

3

19%

86%

2

13%

90%

1

6%

95%

1

6%

100%

4

25%

54
Table 10
Test Score Distribution: Last Attempt
Test Score %

Count

Percent

29%

1

6%

81%

5

31%

86%

2

13%

90%

3

19%

95%

1

6%

100%

4

25%

As noted above, scores improved for those four participants who opted to
remediate and retake the posttest. There remained only one outlier as that participant
opted out of retesting.
Tables 11 to 31 summarize the responses to the test questions based on the last
attempt. There were a total of 16 responses for each question. In each question, the
correct answer is denoted by the star symbol (*).
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Table 11
Responses to Question 1 of Posttest
Question

Responses

Percent

a. Parathyroid hormone, metallic salts
or albumin*

12

75%

b. Vitamin D, parathyroid hormone

2

13%

c. Iron, hyperphosphatemia

0

0%

d. ESRD, hyperphosphatemia

2

13%

1. The Seyle concept of calciphylaxis described a
synthesizer/challenger interaction. Introduction
of a synthesizer such as_____, resulted in
increased calcium and phosphorus. After a
latency period, exposure to a challenger, such as
_______ produced inflammation, acute tissue
ischemia, and tissue necrosis.

Table 12
Responses to Question 2 of Posttest
Question

Responses

Percent

a. 40%

0

0%

b. 60%

1

6%

c. 80% *

15

94%

d. 100%

0

0%

2. Once ulceration develops, the mortality rate can increase to:
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Table 13
Responses to Question 3 of Posttest
Question

Responses

Percent

a. Indurated plaque

0

0%

b. Pain*

15

94%

c. Ulceration

1

6%

d. Bleeding

0

0%

Ischemia

0

0%

Responses

Percent

a. Cardiac complications

0

0%

b. Skin necrosis

0

0%

c. Infection and sepsis*

16

100%

d. Bleeding

0

0%

3. Which is a “hallmark” sign of calciphylaxis:

e.

Table 14
Responses to Question 4 of Posttest
Question

4. The primary cause of death from calciphylaxis is from:
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Table 15
Responses to Question 5 of Posttest
Question

Responses

Percent

a. Diabetic ulcer

2

13%

b. Myocardial infarction*

14

88%

c. Peripheral vascular disorder

0

0%

d. Decubitus ulcer

0

0%

Responses

Percent

a. Pain intensity, eating habits, and general attitude

0

0%

b. Pain frequency, energy levels, and general
awareness

0

0%

c. Pill burden, exhaustion, and general alertness’

0

0%

d. Pain on average, enjoyment of life, and general
activity*

16

100%

5. Calciphylaxis can be characterized as the cutaneous
equivalent of a:

Table 16
Responses to Question 6 of Posttest
Question
6. The PEG pain scale is a three-item pain scale that assesses
what three indicators:
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Table 17
Responses to Question 7 of Posttest
Question

Responses

Percent

a. Acute pain

0

0%

b. Chronic pain

1

6%

c. Response to therapy*

11

69%

d. Current pain levels

4

25%

Responses

Percent

a. Cinacalcet (Senispar)

0

0%

b. Sodium Thiosulfate*

13

81%

c. Sevelamer (Renvela)

2

13%

d. Pamidronic Acid (Aredia)

1

6%

7. The PEG pain scale is a useful tool to determine:

Table 18
Responses to Question 8 of Posttest
Question

8. A number of pharmacologic agents can be used in the
treatment of calciphylaxis. Which one agent is a chelating
agent for calcium:
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Table 19
Responses to Question 9 of Posttest
Question

Responses

Percent

a. 10 minutes

1

6%

b. 30 minutes

2

13%

c. 60 minutes*

13

81%

d. 90 minutes

0

0%

Responses

Percent

a. GI complaints

1

6%

b. Impaired bone integrity

0

0%

c. Metabolic acidosis

0

0%

d. None of the above

0

0%

e. All of the above*

15

94%

9. To minimize the risk of complications, sodium thiosulfate
should be infused over:

Table 20
Responses to Question 10 of Posttest
Question

10. What are possible adverse effects of sodium thiosulfate?
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Table 21
Responses to Question 11 of Posttest
Question

Responses Percentage

11. Some case reports identified calciphylaxis as an
underlying cause of:
a. GI bleeding

0

0%

b. Temporal arteritis

2

13%

c. Cardiomyopathy

2

13%

d. All of the above*

11

69%

e. None of the above

1

6%

Table 22
Responses to Question 12 of Posttest
Question

Responses

Percent

a. Typical, genitals and digits

2

13%

b. Typical, buttocks and thighs

1

6%

c. Atypical, buttocks and thighs

0

0%

d. Atypical, genitals and digits*

13

81%

12. Acral ischemia is a(n) _____ presentation involving the
____:
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Table 23
Responses to Question 13 of Posttest
Question

Responses

Percent

a. Acral*

15

94%

b. Distal

1

6%

c. Proximal

0

0%

d. Medial

0

0%

Responses

Percent

a. Early stage

0

0%

b. Mid stage

1

6%

c. Late stage*

15

94%

13. This image is an example of what type of calciphylaxis
lesion? (the embedded link took the participant to an image
for identification of the lesion)

Table 24
Responses to Question 14 of Posttest
Question
14. Name the stage of lesion – select the letter that corresponds
to the image. (the embedded link took the participant to an
image for identification of the lesion)
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Table 25
Responses to Question 15 of Posttest
Question

Responses

Percent

a. Early stage

2

13%

b. Mid stage*

13

81%

c. Late stage

1

6%

Responses

Percent

a. Early stage*

15

94%

b. Mid stage

1

6%

c. Late stage

0

0%

15. Name the stage of lesion – select the letter that corresponds
to the image. (the embedded link took the participant to an
image for identification of the lesion)

Table 26
Responses to Question 16 of Posttest
Question
16. Name the stage of lesion – select the letter that corresponds
to the image. (the embedded link took the participant to an
image for identification of the lesion)

63
Table 27
Responses to Question 17 of Posttest
Question

Responses

Percent

a. Livedo racemose – like purpura

1

6%

b. Indurated plaque

0

0%

c. Hemorrhagic patches*

11

69%

d. Subcutaneous nodules

0

0%

e. Necrotic ulceration

4

25%

Responses

Percent

a. Livedo racemose – like purpura

0

0%

b. Indurated plaque*

13

81%

c. Hemorrhagic patches

2

13%

d. Subcutaneous nodules

1

6%

e. Necrotic ulceration

0

0%

17. Identify the calciphylaxis lesion. Select the letter that
corresponds to the image. (the embedded link took the
participant to an image for identification of the lesion)

Table 28
Responses to Question 18 of Posttest
Question

18. Identify the calciphylaxis lesion. Select the letter that
corresponds to the image. (the embedded link took the
participant to an image for identification of the lesion)
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Table 29
Responses to Question 19 of Posttest
Question

Responses

Percent

a. Livedo racemose – like purpura*

15

94%

b. Indurated plaque

0

0%

c. Hemorrhagic patches

0

0%

d. Subcutaneous nodules

1

6%

e. Necrotic ulceration

0

0%

Responses

Percent

1

6%

0

0%

1

6%

0

0%

14

88%

19. Identify the calciphylaxis lesion. Select the letter that
corresponds to the image. (the embedded link took the
participant to an image for identification of the lesion)

Table 30
Responses to Question 20 of Posttest
Question

20. Identify the calciphylaxis lesion. Select the letter that corresponds to the
image. (the embedded link took the participant to an image for
identification of the lesion)
a.

Livedo racemose – like purpura

b.

Indurated plaque

c.

Hemorrhagic patches

d.

Subcutaneous nodules

e.

Necrotic ulceration*
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Table 31
Responses to Question 21 of Posttest
Question

Responses

Percent

0

0%

1

6%

21. Identify the calciphylaxis lesion. Select the letter that corresponds to the
image. (the embedded link took the participant to an image for
identification of the lesion)
a.

Livedo racemose – like purpura

b.

Indurated plaque

c.

Hemorrhagic patches

0

0%

d.

Subcutaneous nodules*

13

81%

f.

Necrotic ulceration

2

13%

Areas of weakness on the test were mainly with identification of the different
wound types. In reality, it is not important that the staff can identify the stage or severity
of the wound type. Diagnosis of calciphylaxis is generally based on clinical presentation.
Emphasis is placed on the identification of a wound in the clinical setting, rather than the
stage or type of wound. The exemplars of wounds discussed during the live event and
presented on the posttest are indications a few of the different ways in which
calciphylaxis wounds can manifest in actual practice.
Activity Specific/Outcome Measure Evaluation
The activity specific/outcome measure evaluation comprised two questions.
Question 1. The first question utilized a 5-point Likert scale and asked
participants to rate their responses on a scale of 1 (strongly disagree) to 5 (strongly
agree) to the following question: “After attending this educational offering, I have a
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better knowledge base to assess, identify, and implement practices, which may improve
outcomes for patients with calciphylaxis”. Fourteen participants completed this survey.
There were 13 who responded with a 5 (strongly agree) and one with a response of 3
(neutral). The mean of all respondents was 4.857. The overall response rate would
indicate that the teaching strategies used for the educational activity were effective in
teaching the staff to incorporate this knowledge in clinical practice.
Question 2. Thirteen participants responded to the second question, which asked
them to name one thing learned that could be implemented into current practice. As Table
32 shows, participants retained concepts that were emphasized in the educational activity
such as (a) high mortality rates, (b) early recognition and treatment, (c) the importance of
the pain assessment, (d) patient education, and (e) the importance of calciphylaxis
screening.
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Table 32
One Thing I Learned by Attending This Presentation Is:
Participant

Answer

Response 1

Treatment of calciphylaxis.

Response 2

Identification and classification of different lesions.

Response 3

As a SW, I now have a greater understanding of calciphylaxis.

Response 4

Importance of a good physical exam.

Response 5

You can never ask enough questions about pain.

Response 6

Better assessment skills to screen for calciphylaxis.

Response 7

My increased knowledge on the subject will help me educate my
patients.

Response 8

Calciphylaxis death.

Response 9

Being more aware of calciphylaxis and screening more for it. It is
critical to catch it early and important to advocate for the patients.

Response 10

I have learned some of the benefits of the PEG Pain Scale and
will be able to implement this scale into my practice.
This multidimensional scale with help me understand my
patient’s response to treatment by assessing what my patients
pain on average, enjoyment of life, and general activity is.

Response 11

How to better assess for calciphylaxis and how to determine what
stage a lesion is.

Response 12

Signs and symptoms of calciphylaxis and importance of early
diagnosis.

Response 13

Using a more holistic pain scale.
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Shared Enduring Activity Evaluation
The shared enduring activity evaluation is an assessment to determine if the
participant was able to achieve the program objectives and assure that the activity was
free from commercial bias. Twelve participants completed the shared enduring activity
evaluation. The evaluation contained nine questions.
Question 1. “The content of this presentation was free from bias, commercial
influence and product promotion”. Twelve respondents (100%) answered true.
Question 2. “Please note below if you noted bias, commercial influence or
product promotion within this presentation”. Four respondents’ answers indicated no
bias. Eight respondents made no comment.
Question 3. “I attest that I attended this activity”. Twelve respondents (100%)
attested affirmatively.
Question 4. Question 4 contained two queries and the respondents were asked to
rate each according to the following scale: 1 = strongly disagree, 2 = disagree, 3 =
neutral, 4 = agree, 5 = strongly agree. Table 33 illustrates that all 12 respondents felt that
this presenter demonstrated knowledge and expertise in the content area. The second
query regarded content relevance to practice. In response to this question, one respondent
(8%) rated the relevance as 3 (neutral). The other 11 respondents (92%) answered with a
rating of 5 .
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Table 33
Question 4: Please Rate the Following
Question
The presenter demonstrated knowledge
and expertise in the content area

Scale
1 = Strongly Disagree
2
3
4
5 = Strongly Agree

The subject matter was relevant to my
current practice

1 = Strongly Disagree
2
3
4
5 = Strongly Agree

Count Percent
0
0%
0
0%
0
0%
0
0%
12
100%

0
0
1
0
11

0%
0%
8%
0%
92%

(1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree)
Question 5. The material in this presentation enhanced my knowledge, skills,
and/or practice. Table 34, outlines the responses and showed that 67% of participants
noted that they had gained knowledge as a result of the presentation.
Table 34
Question 5. The Material in This Presentation Enhanced my Knowledge, Skills, and/or
Practice
Response
Knowledge – I have learned

Count
8

Percent
67%

Skills – I can perform

1

8%

Practice – I can implement or change

3

25%

Question 6. Commitment to change practice. The purpose of the commitment to
change practice evaluation is multifactorial and can be a powerful measure of evaluating
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how effectively the learning activity impacted the application of newly acquired
knowledge and implementation of this knowledge into clinical practice (Shershneva,
Wang, Lindeman, Savoy, & Olson, 2010). Table 35 demonstrates that 67% of
respondents intended to make a change to their current practice as a result of this
educational activity. One respondent (8%) anticipated some barriers that might hinder a
change in practice.
Table 35
Question 6: Commitment to Change Practice
Response
I will make a change to my current practice as a result of
the educational session

Count Percent
8
67%

I am considering a change in my current practice as a result
of the educational session

2

17%

This educational session confirms my current practice

1

8%

I am not yet convinced that any change in practice is
warranted

0

0%

I perceive that there may be barriers to changing my
practice (further detail can be provided in Q8)

1

8%

Question 7. What information from this session do you plan to implements in
practice? This query solicited a free text entry. Six participants answered this question.
Table 36 outlines the responses.
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Table 36
Question 7: What Information From This Session Do You Plan to Implement Into
Practice?
Participant
Response 1

Answer
How to treat calciphylaxis

Response 2

Monthly assessment

Response 3

Using screening tool

Response 4

Using the screening tool as a way to advocate to
MDs for my patients

Response 5

PEG Pain Scale

Response 6

The PEG pain tool

Question 8. What are the perceived barriers to implementing information from
this session into practice? This query solicited a free text response. Eight respondents
commented and Table 37 outlines their responses. The responses indicated that the most
perceived barrier is acceptance and incorporation into practice by the organization as the
assessment tool is not validated. These are legitimate concerns that need to be addressed
in future endeavors.
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Table 37
Question 8: What Are Perceived Barriers to Implementing Information From This
Session Into Practice?
Participant
Response 1

None

Answer

Response 2

None

Response 3
Response 4

As a SW [social worker], I will direct concerns to
RNs, NPs, and MDs
Company policy and procedure

Response 5

Not approved for use

Response 6

I think others are too cautious to consider
calciphylaxis as a diagnosis. I believe others just
don’t know enough about it. I am grateful for the
education.

Response 7

N/A

Response 8

Patient’s participating and being truthful on
assessment

Additional comments regarding barriers were discussed during the live
presentation. One nurse commented that she was afraid of over-reaching and acting
outside the scope of nursing practice because she felt she was making a medical
diagnosis. While this is a valid concern, I stressed that she was not making a diagnosis,
but rather was conducting an assessment and reporting findings to a provider for further
evaluation.
Question 9. Provide any additional feedback that you may have about the
material, the author/presenter of ideas for other educational offerings that would be of
interest to you. Five participants commented and their responses are outlined in table 38.
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Table 38
Question 9: Provide Any Additional Feedback That You May Have About the Material,
the Author/Presenter of Ideas for Other Educational Offerings That Would Be of Interest
to You
Participant
Response 1

Answer
Great presentation and presenter very
knowledgeable in subject

Response 2

Very informative

Response 3

It was extremely helpful and will be information I
use for years to come. Thanks

Response 4

N/A

Response 5

I thought that this presentation was very
informational helped me to better understand
calciphylaxis and how to assess for it. The images
were also helpful in order to help determine what
stage the lesions were

Evaluation of the Calciphylaxis Risk Assessment and Screening Tool
The final evaluation focused on the calciphylaxis screening tool. This was a 10question evaluation aimed at appraising the screening instrument for functionality and
workability for use in the clinical setting. A total of 25 participants completed the
evaluation. As tables 39 to 48 show, the assessment form overall was well received with
some suggestions for improvement.
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Table 39
Calciphylaxis Screening Tool: Question 1
Answer choices

Responses

Percent

A. Just right

25

100%

B. Too little

0

0%

C. Too much

0

0%

Responses

Percent

A. Engaging

17

68%

B. Neutral

8

32%

C. Disruptive

0

0%

Amount of Information

Comments
Very Useful
Table 40
Calciphylaxis Screening Tool: Question 2
Answer choices
The color scheme is

Comments
Add color/photos for lesions possibly
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Table 41
Calciphylaxis Screening Tool: Question 3
Answer choices

Responses

Percent

A. Very clear

25

100%

B. Somewhat clear

0

0%

C. Not clear at all

0

0%

Responses

Percent

A. Very clear

25

100%

B. Somewhat clear

0

0%

C. Not clear at all

0

0%

Clarity of instructions

Comments
There were no additional comments
Table 42
Calciphylaxis Screening Tool: Question 4
Answer choices
Ease of use

Comments
There were no additional comments

76
Table 43
Calciphylaxis Screening Tool: Question 5
Answer choices

Responses

Percent

A. Sufficient

21

84%

B. Helpful

4

16%

C. Insufficient

0

0%

Responses

Percent

A. Very relevant

24

96%

B. Somewhat relevant

0

0%

C. Not relevant at all

1

1%

Amount of information to guide a systematic review

Comments
There were no additional comments
Table 44
Calciphylaxis Screening Tool: Question 6
Answer choices
Relevance to practice

Comments
Social worker
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As noted, one participant felt that as a social worker, the assessment form was not
relevant to her practice. This concern is valid; as such an assessment would only be
within the scope of practice for registered nurses.
Table 45
Calciphylaxis Screening Tool: Question 7
Answer choices

Responses

Percent

A. Would recommend

24

96%

B. Might recommend

1

4%

C. Would not recommend

0

0%

Would you recommend this form to a colleague?

Comments
There were no additional comments
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Table 46
Calciphylaxis Screening Tool: Question 8
Answer choices

Responses

Percent

19

76%

6

24%

0

0%

Would you anticipate any barriers that might impede
incorporating this tool in your practice?
D. No barriers
E. Maybe
F. Definite barriers

Comments
1.

RN staffing on the ICHD [incenter hemodialysis] floor.
Easy use in home dialysis setting

2.

Nonverbal

3.

Some MDs might not want us assessing/stepping over
boundaries

4.

Engagement of staff
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Table 47
Calciphylaxis Screening Tool: Question 9
Answer choices

Responses

Percent

A. Would use all the time

23

92%

B. Would use sometimes

1

4%

C. Would not use

1

4%

Amount of use

Comments
Social Worker
As previously noted, the assessment form is not appropriate for all
interdisciplinary team members and, therefore, would not be a functional tool in all
situations.
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Table 48
Calciphylaxis Screening Tool: Question 10
Answer choices

Responses

Percent

☆ - Poor

0

0%

☆☆ - Fair

0

0%

☆☆☆ - Good

1

4%

☆☆☆☆ - Excellent

24

96%

Overall, how would you rate the assessment form? (This
was a 4-star rating system)

Weighted average = 3.96

Comments
1. Very good!
2. This was very informative, and this would be a
great tool to implement.
3. You are a genius.
4. Thank you, really enjoyed the presentation.
Learned a lot and one of the best presentations I
have had yet.
5. Instead of hyperphos, hypercal, hypoalb, use
phos >/= ______, Ca >/= ______, alb </=
______; change Coumadin (brand name) to
warfarin.
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Recommendations
When reviewing the subjective and objective results of all the evaluations, the
educational component of this DNP project would indicate that staff did acquire the
knowledge necessary to conduct a calciphylaxis screening and the skills to identify
calciphylaxis lesions in the clinical setting. The screening tool was well received by the
staff and many of the participants asked for a copy of the tool so they could begin
performing assessments on their own. As I stressed to the staff, this tool has not yet been
validated and is not approved for use at the dialysis facility. Until the tool is validated, I
recommended that the tool could be used as an interdisciplinary approach to collaborate
with the ESRD patient and develop a patient-centered plan of care aimed at reducing
disease burden, enhancing quality of life and, ultimately, improving population health.
Strengths and Limitations of the Project
Strengths
This project is the first to evaluate effects of staff education related to the
identification of early calciphylaxis. The screening tool is the first to be developed for use
in clinical practice.
Limitations
This project took place in a single center with a limited and small participant
sample size. Although continuing education credits (1.5 hours) were offered, there were a
very small number of participants who actually claimed these credits. This low number of
continuing education credits may have impacted the sample size negatively for some of
the evaluations. Clearly, the sample sizes were larger for the paper-based evaluations
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conducted immediately after the live event. One remedy to improve the sample size
would have been to add a web-based offering through the Walden University School of
Nursing Continuing Nurse Education Library and opening it to a larger participant pool.
Evaluations conducted at the end of the live activity only evaluated immediate
and short-term knowledge retention. Because routine calciphylaxis screening cannot be
immediately implemented, there is no evidence to evaluate long-term knowledge
retention. There will need to be further studies to determine knowledge retention in the
long-term and to determine whether staff are actually able to identify calciphylaxis
lesions in routine screening. These questions need to be answered outside of my original
DNP project. In the meantime, dissemination of my calciphylaxis education can be
provided to other dialysis clinics locally.
Implementing the screening tool can be an important step to improve population
health. Unfortunately, it has not been validated and, therefore, is not ready to be placed
into practice. The screening tool was well received by the participants as evidenced by
the evaluations. I do have plans to have the tool validated and then disseminate it to other
nephrology providers. I also plan to work with my partner dialysis organization to
integrate calciphylaxis into clinical practice.
Calciphylaxis detection is a secondary prevention nursing action that has potential
for promoting social change by improving patient outcomes, reducing mortality rates in
the end stage renal disease population, and providing empiric data to inform evidencebased therapies for all patients at risk of developing calciphylaxis.
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Section 5: Dissemination Plan
The American Nephrology Nurses Association (ANNA) is an organization that
can provide several avenues for dissemination. ANNA was established in 1969 and
currently has a membership that exceeds 9,000 nephrology professionals (ANNA,
2018a). The Nephrology Nursing Journal is the official journal of ANNA. This journal is
peer reviewed and publishes current research, educational articles, and manuscripts on
current issues of interest to the nephrology community (ANNA, 2018b). ANNA also
hosts two national seminars yearly. I submitted an abstract (Appendix D) and my
application was accepted (Appendix E) to present a poster at the ANNA 2018 National
Symposium. By disseminating my assessment tool, I hope to raise awareness for the need
to conduct routine calciphylaxis screening. Once validated, I plan to introduce the tool to
my partner organization for the purpose of conducting a pilot study and implementing a
calciphylaxis screening program.
As demonstrated, education on calciphylaxis is paramount in any effort to initiate
a successful screening protocol. I plan to develop a continuing education manuscript and
submit this to the Nephrology Nursing Journal for consideration. Lastly, I can prepare a
continuing education webinar add to the Walden University School of Nursing
Continuing Education Library so this education can be shared on a global scale.
Analysis of Self
As I have embarked on my educational journey from the early beginnings of a
registered nurse, to a master level nurse practitioner, and now a doctoral student, I have
come to appreciate how lifelong learning contributes to self-efficacy and competence. I
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also appreciate the value of sharing knowledge with other medical professionals and most
importantly, the populations that we serve. Evidence-based medicine is now the standard
of care, and as I move forward in my career, I will seek out the best evidence to support
of my delivery of care. As I worked on this DNP project, I found that there has been a
lack of evidence to guide the treatment of calciphylaxis, but the nephrology community is
now beginning to produce research in the field that can finally provide the evidence that
is needed to improve clinical outcomes in the nephrology population. Two such studies
are the CALISTA study (ClinicalTrials.gov, 2017) and the VITK-CUA study
(ClinicalTrials.gov, 2014).
The CALISTA study is a Phase 3 clinical trial studying the use of intravenous
sodium thiosulfate in acute calciphylaxis. This research is being conducted as a
multicenter, randomized, double-blind, placebo-controlled study (ClinicalTrials.gov,
2017). The evaluation of vitamin K supplementation for calcific uremic arteriolopathy
(VITK-CUA) study is a pilot study examining the use of vitamin K in patients at risk to
develop calciphylaxis (ClinicalTrials.gov, 2014). It was very exciting to find reference to
these two studies and I will be following them closely.
As I developed my DNP project, I was able to network with several prominent
nephrologists who are actively studying calciphylaxis. As I progress in my role as a DNP,
I will maintain these professional relationships because I realize that research is dynamic
and calciphylaxis management is an area that is now ripe for research.
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Summary
This DNP journey has been one of professional fulfillment. I was able to identify
a longstanding need for calciphylaxis screening and take an active role in improving
patient outcomes. I expanded my professional network by aligning myself with experts in
the field of calciphylaxis research. In this way, I discovered a whole new area of
nephrology research. I was privileged to mentor dialysis staff at point of care and
hopefully played a role in transforming care at the chairside through education.
Once fully developed and validated, the calciphylaxis assessment and screening
tool can be used as an interdisciplinary approach to achieve early intervention by
empowering nephrology nurses to assume a proactive leadership role in calciphylaxis
disease management. Together, the nurse leader and interdisciplinary team members,
collaborating with the ESRD patient, could develop a patient-centered plan of care aimed
at reducing disease burden, enhancing quality of life and improving population health.
The assessment and screening tool has the potential to address a longstanding practice
void in the continuing care of the ESRD population. While developing the calciphylaxis
screening and assessment tool is one stepping stone in calciphylaxis management, it does
not stand alone. Staff and patient education remain integral to improving quality of life in
the ESRD patient population, reducing symptom burden, and decreasing mortality rates.
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